SCHEMBL4087401

SCHEMBL4087401

COC(=O)C(Cc1ccc(Oc2ccc(N)cc2)cc1)NC(=O)OC(C)(C)C

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KLK5 Q9Y337 1/20 0.54
ITGB3 P05106 1/20 0.50
ITGA2B P08514 1/20 0.50
CTSS P25774 6/20 0.47
CTSK P43235 5/20 0.47
CTSL P07711 1/20 0.46
CTSB P07858 1/20 0.46
HDAC8 Q9BY41 1/20 0.46
ACE P12821 1/20 0.45
PPARG P37231 1/20 0.44
PPARA Q07869 1/20 0.44
MMP13 P45452 1/20 0.44
PSEN1 P49768 2/20 0.44
PSEN2 P49810 2/20 0.44
APH1B Q8WW43 2/20 0.44
NCSTN Q92542 2/20 0.44
APH1A Q96BI3 2/20 0.44
PSENEN Q9NZ42 2/20 0.44
MEN1 O00255 1/20 0.44
ALDH1A1 P00352 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8212237 1.00 KLK5 (0.54) KLK5ITGB3ITGA2BCTSSCTSK
SCHEMBL19212612 0.94 KLK5 (0.60) KLK5ITGB3ITGA2BCTSSCTSK
SCHEMBL3316394 0.94 KLK5 (0.60) KLK5ITGB3ITGA2BCTSSCTSK
SCHEMBL3498608 0.94 KLK5 (0.60) KLK5ITGB3ITGA2BCTSSCTSK
Acetic Acid SCHEMBL2728774 0.90 KLK5 (0.59) KLK5ITGB3ITGA2BCTSSCTSK
SCHEMBL2294118 0.89 KLK5 (0.61) KLK5ITGB3ITGA2BCTSSCTSK
SCHEMBL15910014 0.89 KLK5 (0.55) KLK5CTSSCTSKCTSLCTSB
SCHEMBL29103443 0.89 KLK5 (0.61) KLK5ITGB3ITGA2BCTSSCTSK
SCHEMBL29721250 0.89 KLK5 (0.61) KLK5ITGB3ITGA2BCTSSCTSK
SCHEMBL2294112 0.89 KLK5 (0.61) KLK5ITGB3ITGA2BCTSSCTSK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090082408-A1 NOVEL HETEROCYCLIC DERIVATIVES ORCHID RESEARCH LABORATORIES LIMITED (IN) 2009-03-26 US disclosed
US-20090082408-A1 NOVEL HETEROCYCLIC DERIVATIVES ORCHID RESEARCH LABORATORIES LIMITED (IN) 2009-03-26 US disclosed
US-20090082408-A1 NOVEL HETEROCYCLIC DERIVATIVES ORCHID RESEARCH LABORATORIES LIMITED (IN) 2009-03-26 US disclosed
WO-2008029217-A2 DIPEPTIDYL PEPTIDASE IV INHIBITORS ORCHID RESEARCH LABORATORIES LIMITED (IN) 2008-03-13 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090082408-A1 NOVEL HETEROCYCLIC DERIVATIVES CYP3A5, CYP3A7, UGT2B7 KLK5 1276/4885ITGB3 3666/4885ITGA2B 3255/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.